Total Payments
$261,660
2024 Payments
$76,784
Companies
20
Transactions
189
Medicare Patients
796
Medicare Billing
$166,962
Payment Breakdown by Category
Other$213,960 (81.8%)
Consulting$25,985 (9.9%)
Travel$17,413 (6.7%)
Food & Beverage$4,258 (1.6%)
Education$44.85 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $213,960 | 50 | 81.8% |
| Consulting Fee | $25,985 | 20 | 9.9% |
| Travel and Lodging | $17,413 | 33 | 6.7% |
| Food and Beverage | $4,258 | 83 | 1.6% |
| Education | $44.85 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $225,468 | 126 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $14,081 | 4 | $0 (2024) |
| ARRAY BIOPHARMA INC | $6,080 | 3 | $0 (2021) |
| Merck Sharp & Dohme LLC | $5,748 | 9 | $0 (2024) |
| Amgen Inc. | $3,199 | 3 | $0 (2023) |
| PFIZER INC. | $2,537 | 2 | $0 (2020) |
| GENZYME CORPORATION | $1,985 | 1 | $0 (2021) |
| Tempus AI, Inc | $1,396 | 7 | $0 (2024) |
| Daiichi Sankyo Inc. | $597.11 | 7 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $180.18 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $76,784 | 51 | E.R. Squibb & Sons, L.L.C. ($69,138) |
| 2023 | $86,637 | 48 | E.R. Squibb & Sons, L.L.C. ($83,322) |
| 2022 | $52,791 | 43 | E.R. Squibb & Sons, L.L.C. ($47,789) |
| 2021 | $37,251 | 22 | E.R. Squibb & Sons, L.L.C. ($22,444) |
| 2020 | $7,645 | 6 | E.R. Squibb & Sons, L.L.C. ($2,600) |
| 2019 | $308.03 | 6 | E.R. Squibb & Sons, L.L.C. ($154.19) |
| 2018 | $138.03 | 7 | Novartis Pharmaceuticals Corporation ($138.03) |
| 2017 | $106.57 | 6 | Novartis Pharmaceuticals Corporation ($23.26) |
All Payment Transactions
189 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,988.00 | General |
| Category: Oncology | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,352.00 | General |
| Category: Oncology | ||||||
| 11/15/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Oncology | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Travel and Lodging | Cash or cash equivalent | $781.42 | General |
| Category: Oncology | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $103.15 | General |
| Category: Oncology | ||||||
| 11/06/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Travel and Lodging | Cash or cash equivalent | $758.28 | General |
| Category: Oncology | ||||||
| 11/06/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Oncology | ||||||
| 10/28/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $117.35 | General |
| 10/28/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $27.58 | General |
| 10/28/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $24.01 | General |
| 10/18/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Oncology | ||||||
| 09/20/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,082.00 | General |
| Category: Oncology | ||||||
| 09/20/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $28.76 | General |
| Category: ONCOLOGY | ||||||
| 08/31/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $52.90 | General |
| Category: Oncology | ||||||
| 08/31/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Travel and Lodging | Cash or cash equivalent | $36.79 | General |
| Category: Oncology | ||||||
| 08/29/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,964.00 | General |
| Category: Oncology | ||||||
| 08/19/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,658.00 | General |
| Category: Oncology | ||||||
| 08/16/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Oncology | ||||||
| 08/07/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,275.00 | General |
| Category: ONCOLOGY | ||||||
| 07/22/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,658.00 | General |
| Category: Oncology | ||||||
| 07/19/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: ONCOLOGY | ||||||
| 07/17/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,658.00 | General |
| Category: Oncology | ||||||
| 07/08/2024 | Tempus AI, Inc | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 145 | 377 | $116,979 | $38,308 |
| 2022 | 7 | 189 | 396 | $128,095 | $42,851 |
| 2021 | 5 | 201 | 439 | $149,032 | $50,261 |
| 2020 | 8 | 261 | 443 | $127,524 | $35,542 |
Total Patients
796
Total Services
1,655
Medicare Billing
$166,962
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 84 | 290 | $92,794 | $30,817 | 33.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 44 | 70 | $16,450 | $5,217 | 31.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 17 | 17 | $7,735 | $2,274 | 29.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 74 | 249 | $80,085 | $27,789 | 34.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 27 | $11,727 | $3,774 | 32.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 19 | $8,512 | $3,000 | 35.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 14 | 14 | $6,558 | $1,972 | 30.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 18 | 23 | $5,405 | $1,642 | 30.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 13 | 21 | $4,851 | $1,542 | 31.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 12 | 12 | $4,482 | $1,221 | 27.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 17 | $4,235 | $1,218 | 28.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 14 | 14 | $2,240 | $692.46 | 30.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 61 | 191 | $61,123 | $22,135 | 36.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 20 | 78 | $35,958 | $11,316 | 31.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 60 | 100 | $23,740 | $7,800 | 32.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 21 | 23 | $10,304 | $3,522 | 34.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 16 | 16 | $7,280 | $2,412 | 33.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 11 | 19 | $6,145 | $1,854 | 30.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 12 | 12 | $4,482 | $1,222 | 27.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 57 | 131 | $43,075 | $11,573 | 26.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 70 | 127 | $31,405 | $7,532 | 24.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 23 | 25 | $11,200 | $4,109 | 36.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 11 | 38 | $8,778 | $3,205 | 36.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 31 | 31 | $11,816 | $3,022 | 25.6% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 15 | 15 | $6,825 | $2,025 | 29.7% |
About Dr. Daniel Johnson, M.D
Dr. Daniel Johnson, M.D is a Internal Medicine healthcare provider based in New Orleans, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/20/2012. The National Provider Identifier (NPI) number assigned to this provider is 1841565173.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Johnson, M.D has received a total of $261,660 in payments from pharmaceutical and medical device companies, with $76,784 received in 2024. These payments were reported across 189 transactions from 20 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($213,960).
As a Medicare-enrolled provider, Johnson has provided services to 796 Medicare beneficiaries, totaling 1,655 services with total Medicare billing of $166,962. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Student in an Organized Health Care Education/Training Program, Medical Oncology
- Location New Orleans, LA
- Active Since 03/20/2012
- Last Updated 08/06/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1841565173
Products in Payments
- OPDIVO (Biological) $220,328
- IMFINZI (Biological) $14,081
- BRAFTOVI (Drug) $8,605
- KEYTRUDA (Biological) $5,730
- LIBTAYO (Biological) $1,985
- TASIGNA (Drug) $161.29
- Enhertu (Drug) $127.11
- Tempus Pixel (Device) $103.22
- LUMAKRAS (Drug) $94.79
- BRUKINSA (Drug) $73.81
- ERLEADA (Drug) $55.80
- Nubeqa (Drug) $49.16
- DARZALEX (Biological) $47.90
- Xtandi (Drug) $22.99
- KRAZATI (Drug) $21.00
- Alecensa (Biological) $20.80
- PADCEV (Biological) $19.23
- MEKINIST (Drug) $18.89
- Nplate (Biological) $17.68
- IMBRUVICA (Drug) $17.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in New Orleans
Dr. Steven Deitelzweig, Md, MD
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M
Dr. Nassir Marrouche, M.d, M.D
Internal Medicine — Payments: $800,684
Internal Medicine $800,684
Sarah Glover, Do, DO
Internal Medicine — Payments: $250,533
Internal Medicine $250,533
Laura Finn, M.d, M.D
Internal Medicine — Payments: $156,942
Internal Medicine $156,942
Dr. Lesley Saketkoo, Md; Mph, MD; MPH
Internal Medicine — Payments: $101,239
Internal Medicine $101,239
Adil Yousuf, Md, MD
Internal Medicine — Payments: $75,842
Internal Medicine $75,842